Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Emergent BioSolutions Inc. (EBS)

103.64   2.01 (1.98%) 09-29 01:07
Open: 102.28 Pre. Close: 101.63
High: 103.8 Low: 101.18
Volume: 355,909 Market Cap: 5,485M
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. The company is headquartered in Gaithersburg, Maryland and currently employs 1,705 full-time employees. The firm focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. The company focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. The company operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 103.928 - 104.313 104.313 - 104.623
Low: 100.141 - 100.625 100.625 - 101.015
Close: 102.904 - 103.661 103.661 - 104.269

Technical analysis

as of: 2020-09-28 4:31:55 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 138.56     One year: 153.97
Support: Support1: 97.30    Support2: 80.95
Resistance: Resistance1: 118.63    Resistance2: 131.82
Pivot: 101.61
Moving Average: MA(5): 101.47     MA(20): 103.61
MA(100): 96.91     MA(250): 73.51
MACD: MACD(12,26): -3.39     Signal(9): -3.53
Stochastic oscillator: %K(14,3): 38.35     %D(3): 30.01
RSI: RSI(14): 45.57
52-week: High: 137.61  Low: 46.37  Change(%): 97.9
Average Vol(K): 3-Month: 91366  10-Days: 52115

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
EBS has closed below upper band by 23.6%. Bollinger Bands are 70.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to EBS's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 25 Sep 2020
Emergent BioSolutions Inc. (EBS) Is Posting Gains, Do You Know Why? - investmillion.com

Fri, 25 Sep 2020
Fuad El-Hibri Sells 25,535 Shares of Emergent Biosolutions Inc (NYSE:EBS) Stock - MarketBeat

Mon, 21 Sep 2020
Emergent BioSolutions Sees Hammer Chart Pattern: Time to Buy? - Yahoo Finance

Fri, 18 Sep 2020
Has Emergent Biosolutions (EBS) Outpaced Other Medical Stocks This Year? - Nasdaq

Wed, 16 Sep 2020
ValuEngine Downgrades Emergent Biosolutions (NYSE:EBS) to Sell - MarketBeat

Fri, 11 Sep 2020
Emergent Biosolutions (EBS) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 53
Shares Float (M) 47
% Held by Insiders 15.60
% Held by Institutions 88.96
Shares Short (K) 2,470
Shares Short P. Month (K) 2,570

Stock Financials

EPS 3.190
EPS Est This Year 1.540
EPS Est Next Year 2.260
Book Value (p.s.) 22.660
Profit Margin 13.52
Operating Margin 23.80
Return on Assets (ttm) 7.8
Return on Equity (ttm) 15.6
Qtrly Rev. Growth 62.3
Gross Profit (p.s.) 9.129
Sales Per Share 23.810
EBITDA (p.s.) 7.721
Qtrly Earnings Growth
Operating Cash Flow (M) 305
Levered Free Cash Flow (M) 157

Stock Valuations

PE Ratio 32.49
PEG Ratio
Price to Book value 4.57
Price to Sales 4.35
Price to Cash Flow 18.00

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.